Maine Revised Statutes Title 32 Sec. 13794 – Labeling of prescriptions
Current as of: 2023 | Check for updates
|
Other versions
Terms Used In Maine Revised Statutes Title 32 Sec. 13794
- Drug: means :
A. See Maine Revised Statutes Title 32 Sec. 13702-AInterchangeable biological product: means a biological product that the federal Food and Drug Administration has:
A. See Maine Revised Statutes Title 32 Sec. 13702-Alegend drug: means a drug that:
A. See Maine Revised Statutes Title 32 Sec. 13702-APharmacy: means :
A. See Maine Revised Statutes Title 32 Sec. 13702-APractitioner: means an individual who is licensed, registered or otherwise authorized in the appropriate jurisdiction to prescribe and administer drugs in the course of professional practice. See Maine Revised Statutes Title 32 Sec. 13702-A therapeutically equivalent drug: means any drug that has identical amounts of the same active ingredients in the same dosage form and in the same concentration that, when administered in the same amounts, will produce or can be expected to have the same therapeutic effect as the drug prescribed. See Maine Revised Statutes Title 32 Sec. 13702-A
Every drug dispensed pursuant to prescription, whether for a legend drug or not, must carry on the label the following information: the prescription number; the date of filling; the patient’s name; directions for use; the name and strength of the drug and the amount dispensed, including either the brand name of the drug or, if a generic and therapeutically equivalent drug or interchangeable biological product is dispensed the label must be in accordance with section 13781; the beyond use date of the drug; the name of the practitioner prescribing the drug; and the name, address and telephone number of the pharmacy where the prescription was compounded and dispensed. For purposes of this section, “beyond use date” means a date beyond which the contents of the prescription are not recommended to be used. [PL 2019, c. 34, §5 (AMD).]
A drug dispensed in accordance with the provisions of Title 22, chapter 251, subchapter 3, article 5 does not require the name of the patient’s sexual partner on the label. [PL 2009, c. 533, §5 (NEW).]
SECTION HISTORY
PL 1987, c. 710, §5 (NEW). PL 1999, c. 130, §14 (AMD). PL 2009, c. 533, §5 (AMD). PL 2019, c. 34, §5 (AMD).